Ticker Details
Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
IPO Date:	December 1, 2013
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$1.05B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.03 | 3.10%
Avg Daily Range (30 D):	$0.61 | 3.68%
Avg Daily Range (90 D):	$0.74 | 3.98%

Institutional Daily Volume
Avg Daily Volume:	.96M
Avg Daily Volume (30 D):	1.95M
Avg Daily Volume (90 D):	1.87M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	75

Institutional Trades
Total Institutional Trades:	7,380
Avg Institutional Trade:	$2.73M
Avg Institutional Trade (30 D):	$2.36M
Avg Institutional Trade (90 D):	$2.21M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.86M
Avg Closing Trade (30 D):	$5.49M
Avg Closing Trade (90 D):	$4.85M
Avg Closing Volume:	116.49K

News

Apr 24, 2026 @ 6:18 PM FDA Flags High-Risk Recall For Tandem Diabetes Mob... Source: Vandana Singh

Mar 27, 2026 @ 1:00 PM Tandem Diabetes Care, Inc. Investigated by the Por... Source: Portnoy Law Firm

Mar 9, 2026 @ 10:30 PM [Latest] Global Intravenous Infusion Pump Market S... Source: Custom Market Insights

Feb 20, 2026 @ 6:01 PM Tandem Diabetes Shares Rise 33% On Earnings Beat, ... Source: Vandana Singh

Feb 8, 2026 @ 5:23 PM TNDM Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.4	$-.3	$-.01
Diluted EPS	$-1.4	$-.3	$-.01
Revenue	$1.03B	$247.22M	$290.38M
Gross Profit	$564.4M	$136.79M	$167.46M
Net Income / Loss	$-94.55M	$-20.39M	$-.59M
Operating Income / Loss	$-83.81M	$-17.43M	$8.29M
Cost of Revenue	$463.14M	$110.43M	$122.92M
Net Cash Flow	$125.75M	$88.69M	$-1.31M
PE Ratio

Splits
Oct 10, 2017	1:10